Study finds exercise decreases among people taking GLP-1 medication

Article excerpt

Adults taking GLP-1 medications to lose weight, drugs like semaglutide that have become wildly popular, significantly cut back on exercise, a study presented at the Endocrine Society's annual meeting found. The research raises a red flag: while these medications shrink waistlines fast, the sedentary shift threatens muscle loss, a key marker of healthy aging. GLP-1 drugs work by suppressing appetite and slowing stomach emptying, making people feel fuller longer. But the study suggests the medications may inadvertently remove a powerful motivator for movement. Researchers worry that without aggressive intervention, weight-loss drug users could trade obesity for a different health hazard: muscle wasting and frailty.